BioSpace News Archive

The UK genomic tools developer, RevoluGen Ltd., announces that its divisional method patent has been granted by the UK Intellectual Patent Office.

Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, announced that the U.S. Food and Drug Administration has placed a clinical hold on its clinical trial evaluating eprenetapopt with acalabrutinib or with venetoclax and rituximab in lymphoid malignancies.

Vivet Therapeutics, a clinical-stage biotechnology company, and Pfizer Inc. announced the U.S. Food and Drug Administration has granted Fast Track designation to VTX-801, Vivet’s clinical-stage gene therapy for the treatment of Wilson Disease – a rare, genetic disorder that reduces the ability of the liver and other tissues to regulate copper levels, causing severe hepatic damage, neurological symptoms, and potentially death.

Ikena Oncology, Inc., a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, announced financial results for the quarter that ended June 30, 2021.

CASI Pharmaceuticals, Inc. today reported financial results for the second quarter of 2021.

Precision BioSciences, Inc. today announced financial results for the second quarter ended June 30, 2021 and provided a business update.

Cybin Inc. is pleased to announce that Adelia Therapeutics Inc. (“ Adelia ”), a wholly-controlled subsidiary of Cybin, has achieved certain milestones for Year 1 Q3 (i)-(iii), and Year 1 Q4 (iii), as contemplated by the terms of a contribution agreement dated December 4, 2020

VectivBio Holding AG today published the invitation to the Extraordinary General Meeting, which will be held on Thursday, September 2, 2021, at 2:00 p.m. CEST / 8:00 a.m. EDT

Organon today announced its results for the second quarter and year to date ended June 30, 2021 and affirmed its full year 2021 financial guidance.

Electronic pills were first invented in 1972 by Dr. Eric Johannessen and Professor John Cooper.